Since the context of antigen presentation is critical to mimic human B cell infection, the choice of cell type for the challenge tumor line may significantly influence important characteristics of the function of LMP1 in vivo, as well as the effectiveness of an anti-LMP1 immunotherapy. The gene discussed is PDLIM7; the disease is neoplasm.